SCOTTISH MEDICINES CONSORTIUM
NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
PAPIG
PAPIG, the Public and Patient Involvement Group, is a subgroup of SMC. Membership is comprised of no less than 6 members of SMC, 3 of whom must be public partners. Public partners are appointed from the general public. PAPIG meets bimonthly, normally immediately before an SMC meeting. A public partner acts as Chair.
PAPIG’s Role:
- to make recommendations to SMC on the development of public involvement opportunities;
- to monitor and report back to SMC on the effectiveness of public involvement opportunities where this information is available;
- to ensure that a patient/carer perspective is prominent in all SMC assessments;
- to present a summary of the Patient Interest Group submissions, where these have been submitted, to SMC meetings;
- to promote public awareness of, and involvement in, the work of SMC.
History of Public Involvement in SMC
Today patients are involved in their own healthcare decisions. Communities are consulted when changes take place in their local Health Board and the general public are interested in healthcare policy decisions affecting them.
Our document Patient and Public Involvement Two Years On – A Progress Report tracks the beginnings of SMC’s Public Involvement journey.
The following extracts further illustrate the growing relationship between SMC and the public:
Extract from SMC Annual Report 2002